Supplementary protection
LT - Beta-amino tetrahidroimidazo(1,2-A)pirazinai ir tetrahidrotriazolo(4,3-A)pirazinai kaip dipeptidilpeptidazės inhibitoriai, skirti diabeto gydymui arba prevencijai
EN - BETA-AMINO TETRAHYDROIMIDAZO(1,2-A)PYRAZINES AND TETRAHYDROTRIAZOLO(4,3-A)PYRAZINES AS DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
SPC
| (11) |
Number of the document |
C 1412357 |
| (68) |
Number of the document |
1412357
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2008 013 |
| (22) |
Date of filing the application |
2008-10-07 |
| (41) |
Date of publication of the application |
2008-11-25 |
|
Date of publication of SPC |
2009-06-25 |
| (24) |
Date of coming into effect of SPC |
2022-07-06 |
Applicant
| (71) |
Merck & Co., Inc.,
126 East Lincoln Avenue, Rahway, New Jersey 07065-0907,
US
|
Grantee
| (73) |
Merck Sharp & Dohme LLC,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
Attorney or representative
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/08/455/001 - EU/1/08/455/014, 2008-07-16
|
Calculated date of expiry of the SPC
| (94) |
2023-07-16 |
Name of the product protected by the basic patent
| (95) |
Sitagliptinum phosphas monohydricus, metformini hydrochloridum |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2023-06-23 |
|
347.00
EUR
|
